Published in Cell on December 01, 1978
Nucleotide sequences of the mRNA's encoding the vesicular stomatitis virus G and M proteins determined from cDNA clones containing the complete coding regions. J Virol (1981) 7.97
Transcription and replication of rhabdoviruses. Microbiol Rev (1987) 4.05
Matrix protein of rabies virus is responsible for the assembly and budding of bullet-shaped particles and interacts with the transmembrane spike glycoprotein G. J Virol (1999) 2.70
Influenza virus gene expression: control mechanisms at early and late times of infection and nuclear-cytoplasmic transport of virus-specific RNAs. J Virol (1987) 2.21
Cells that express all five proteins of vesicular stomatitis virus from cloned cDNAs support replication, assembly, and budding of defective interfering particles. Proc Natl Acad Sci U S A (1991) 2.05
Role of matrix protein in cytopathogenesis of vesicular stomatitis virus. J Virol (1990) 2.05
Functional and antigenic domains of the matrix (M1) protein of influenza A virus. J Virol (1987) 1.98
Phenotypic consequences of rearranging the P, M, and G genes of vesicular stomatitis virus. J Virol (1999) 1.89
The vesicular stomatitis virus matrix protein inhibits transcription from the human beta interferon promoter. J Virol (1997) 1.87
RING finger Z protein of lymphocytic choriomeningitis virus (LCMV) inhibits transcription and RNA replication of an LCMV S-segment minigenome. J Virol (2001) 1.84
Mapping regions of the matrix protein of vesicular stomatitis virus which bind to ribonucleocapsids, liposomes, and monoclonal antibodies. J Virol (1986) 1.78
Vesicular stomatitis virus M protein in the nuclei of infected cells. J Virol (1988) 1.67
Regulation of viral transcription by the matrix protein of vesicular stomatitis virus probed by monoclonal antibodies and temperature-sensitive mutants. J Virol (1985) 1.66
Stereo images of vesicular stomatitis virus assembly. J Virol (1986) 1.63
Phenotypic revertants of temperature-sensitive M protein mutants of vesicular stomatitis virus: sequence analysis and functional characterization. J Virol (1987) 1.51
In vitro replication of mouse hepatitis virus strain A59. J Virol (1987) 1.46
Aberrant polyadenylation by a vesicular stomatitis virus mutant is due to an altered L protein. J Virol (1984) 1.46
In vitro synthesis of triphosphate-initiated N-gene mRNA oligonucleotides is regulated by the matrix protein of vesicular stomatitis virus. J Virol (1982) 1.42
Transcription and replication initiate at separate sites on the vesicular stomatitis virus genome. Proc Natl Acad Sci U S A (2002) 1.39
Sequences of the vesicular stomatitis virus matrix protein involved in binding to nucleocapsids. J Virol (1991) 1.35
Purified matrix protein of vesicular stomatitis virus blocks viral transcription in vitro. Proc Natl Acad Sci U S A (1982) 1.34
Crystal structure of vesicular stomatitis virus matrix protein. EMBO J (2002) 1.34
Expression of the M gene of vesicular stomatitis virus cloned in various vaccinia virus vectors. J Virol (1988) 1.33
Nucleotide sequence of the gene encoding respiratory syncytial virus matrix protein. J Virol (1984) 1.31
Cell-free synthesis and assembly of vesicular stomatitis virus nucleocapsids. J Virol (1983) 1.28
Monoclonal antibodies to the M protein of vesicular stomatitis virus (Indiana serotype) and to a cDNA M gene expression product. J Virol (1985) 1.28
Minigenomes, transcription and replication competent virus-like particles and beyond: reverse genetics systems for filoviruses and other negative stranded hemorrhagic fever viruses. Antiviral Res (2011) 1.24
Purification of measles virus and characterization of subviral components. J Virol (1979) 1.20
Sequence alterations in temperature-sensitive M-protein mutants (complementation group III) of vesicular stomatitis virus. J Virol (1985) 1.16
A mutated membrane protein of vesicular stomatitis virus has an abnormal distribution within the infected cell and causes defective budding. J Virol (1987) 1.16
Antigenicity, function, and conformation of synthetic oligopeptides corresponding to amino-terminal sequences of wild-type and mutant matrix proteins of vesicular stomatitis virus. J Virol (1988) 1.14
Recombinant vesicular stomatitis virus as an HIV-1 vaccine vector. Springer Semin Immunopathol (2006) 1.12
Arenavirus Z protein controls viral RNA synthesis by locking a polymerase-promoter complex. Proc Natl Acad Sci U S A (2011) 1.07
Effect of ribavirin on macromolecular synthesis in vesicular stomatitis virus-infected cells. Antimicrob Agents Chemother (1986) 1.06
Vesicular stomatitis virus mRNA and inhibition of translation of cellular mRNA--is there a P function in vesicular stomatitis virus? J Virol (1981) 1.06
Transcription inhibition site on the M protein of vesicular stomatitis virus located by marker rescue of mutant tsO23(III) with M-gene expression vectors. J Virol (1989) 1.04
Mutation in the matrix protein of Newcastle disease virus can result in decreased fusion glycoprotein incorporation into particles and decreased infectivity. J Virol (1984) 1.04
Site-specific mutations in vectors that express antigenic and temperature-sensitive phenotypes of the M gene of vesicular stomatitis virus. J Virol (1988) 1.03
Intracellular distribution of input vesicular stomatitis virus proteins after uncoating. J Virol (1991) 0.99
Restriction of measles virus RNA synthesis by a mouse host cell line: trans-complementation by polymerase components or a human cellular factor(s). J Virol (2002) 0.98
A spatio-temporal analysis of matrix protein and nucleocapsid trafficking during vesicular stomatitis virus uncoating. PLoS Pathog (2010) 0.97
Glycoprotein-dependent acidification of vesicular stomatitis virus enhances release of matrix protein. J Virol (2009) 0.97
RNA synthesis of vesicular stomatitis virus. X. Transcription and replication by defective interfering particles. J Virol (1980) 0.95
Comparison o;f vesicular stomatitis virus intracellular and virion ribonucleoproteins. J Virol (1980) 0.95
Suppression of the Sendai virus M protein through a novel short interfering RNA approach inhibits viral particle production but does not affect viral RNA synthesis. J Virol (2006) 0.94
Borna disease virus matrix protein is an integral component of the viral ribonucleoprotein complex that does not interfere with polymerase activity. J Virol (2006) 0.92
Interferon response and viral evasion by members of the family rhabdoviridae. Viruses (2009) 0.92
Vesicular stomatitis virus in Drosophila melanogaster cells: regulation of viral transcription and replication. J Virol (1988) 0.92
Crystal structure of the Borna disease virus matrix protein (BDV-M) reveals ssRNA binding properties. Proc Natl Acad Sci U S A (2009) 0.91
Architecture and regulation of negative-strand viral enzymatic machinery. RNA Biol (2012) 0.90
Neurovirulence and immunogenicity of attenuated recombinant vesicular stomatitis viruses in nonhuman primates. J Virol (2014) 0.88
Inhibition of vesicular stomatitis virus RNA synthesis by protein hyperphosphorylation. J Virol (1994) 0.88
Novel phenotype of RNA synthesis expressed by vesicular stomatitis virus isolated from persistent infection. J Virol (1982) 0.85
In vitro and in vivo inhibition of primary transcription of vesicular stomatitis virus by a defective interfering particle. J Virol (1982) 0.82
Assembly of vesicular stomatitis virus: distribution of the glycoprotein on the surface of infected cells. J Virol (1982) 0.81
Vesicular stomatitis virus infection promotes immune evasion by preventing NKG2D-ligand surface expression. PLoS One (2011) 0.80
The family Rhabdoviridae: mono- and bipartite negative-sense RNA viruses with diverse genome organization and common evolutionary origins. Virus Res (2016) 0.77
Recombinant Isfahan Virus and Vesicular Stomatitis Virus Vaccine Vectors Provide Durable, Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge. J Virol (2017) 0.75
Role of Viral Hemorrhagic Septicemia Virus Matrix (M) Protein in Suppressing Host Transcription. J Virol (2017) 0.75
Ribonucleic acid synthesis of vesicular stomatitis virus, II. An RNA polymerase in the virion. Proc Natl Acad Sci U S A (1970) 11.83
Defective viral particles and viral disease processes. Nature (1970) 7.24
Comparative sedimentation coefficients of RNA extracted from plaque-forming and defective particles of vesicular stomatitis virus. J Mol Biol (1966) 6.61
Defective T particles of vesicular stomatitis virus. I. Preparation, morphology, and some biologic properties. Virology (1966) 6.37
Ribonucleic acid synthesis of vesicular stomatitis virus. 3. Multiple complementary messenger RNA molecules. Virology (1970) 5.99
Ribonucleic acid synthesis of vesicular stomatitis virus. I. Species of ribonucleic acid found in Chinese hamster ovary cells infected with plaque-forming and defective particles. J Virol (1969) 5.73
Comparison of membrane protein glycopeptides of Sindbis virus and vesicular stomatitis virus. J Virol (1970) 4.54
Ribonucleic acid synthesis of vesicular stomatitis virus. IV. Transcription by standard virus in the presence of defective interfering particles. J Virol (1972) 4.48
Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain. J Neurochem (2001) 4.45
A virion-associated glycoprotein essential for infectivity of herpes simplex virus type 1. Virology (1981) 4.37
Defective interfering viruses. Annu Rev Microbiol (1973) 4.21
Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition. Nat Genet (1997) 4.11
Defective T particles of vesicular stomatitis virus. II. Biologic role in homologous interference. Virology (1966) 3.49
Ribonucleic acid polymerase in virions of Newcastle disease virus: comparison with the vesicular stomatitis virus polymerase. J Virol (1971) 3.34
Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature (1994) 2.99
Initiation of polyribosome formation in poliovirus-infected HeLa cells. J Mol Biol (1970) 2.91
Platelet-derived growth factor and double-stranded ribonucleic acids stimulate expression of the same genes in 3T3 cells. Cell (1985) 2.82
Growth of pseudotypes of vesicular stomatitis virus with N-tropic murine leukemia virus coats in cells resistant to N-tropic viruses. J Virol (1973) 2.75
Cloning of the alpha chain of human platelet glycoprotein Ib: a transmembrane protein with homology to leucine-rich alpha 2-glycoprotein. Proc Natl Acad Sci U S A (1987) 2.70
Absence of interference during high-multiplicity infection by clonally purified vesicular stomatitis virus. J Virol (1971) 2.48
RNA synthesis of vesicular stomatitis virus. V. Interactions between transcription and replication. J Virol (1973) 2.44
Viral pathogenesis and molecular biology. Bacteriol Rev (1977) 2.41
Inhibition of cellular RNA synthesis by nonreplicating vesicular stomatitis virus. Proc Natl Acad Sci U S A (1965) 2.37
Characterization of vesicular stomatitis virus nucleocapsids. I. Complementary 40 S RNA molecules in nucleocapsids. Virology (1974) 2.30
Isopycnic separation of subcellular components from poliovirus-infected and normal HeLa cells. Science (1968) 2.25
A comparative study of virus isolation, polymerase chain reaction, and antigen detection in children of mothers infected with human immunodeficiency virus. J Pediatr (1990) 2.09
Effects of phosphorylation and pH on the association of NS protein with vesicular stomatitis virus cores. J Virol (1978) 2.08
Cloning and expression of a cDNA coding for the human platelet-derived growth factor receptor: evidence for more than one receptor class. Proc Natl Acad Sci U S A (1988) 2.06
Interaction of HeLa cell proteins with RNA. J Mol Biol (1970) 1.90
RNP template of vesicular stomatitis virus regulates transcription and replication functions. Cell (1983) 1.89
Characterization of a cDNA coding for human factor VII. Proc Natl Acad Sci U S A (1986) 1.89
A novel trypsin-like serine protease (hepsin) with a putative transmembrane domain expressed by human liver and hepatoma cells. Biochemistry (1988) 1.89
A retinoic acid-responsive human zinc finger gene, MZF-1, preferentially expressed in myeloid cells. J Biol Chem (1991) 1.83
Nucleotide sequence of the gene coding for human factor VII, a vitamin K-dependent protein participating in blood coagulation. Proc Natl Acad Sci U S A (1987) 1.71
The alpha and beta chains of human platelet glycoprotein Ib are both transmembrane proteins containing a leucine-rich amino acid sequence. Proc Natl Acad Sci U S A (1988) 1.70
Expression of the syncytial (syn) phenotype in HSV-1, strain KOS: genetic and phenotypic studies of mutants in two syn loci. Virology (1981) 1.68
Association of polyadenylic acid with messenger RNA of vesicular stomatitis virus. J Mol Biol (1973) 1.68
Inhibition of RNA and interferon synthesis in Krebs-2 cells infected with vesicular stomatitis virus. Virology (1966) 1.67
An inversion that disrupts the Antennapedia gene causes abnormal structure and localization of RNAs. Cell (1986) 1.64
Cloning, expression, and gene structure of a G protein-coupled glutamate receptor from rat brain. Science (1991) 1.62
Reactive glia express cytosolic phospholipase A2 after transient global forebrain ischemia in the rat. Stroke (1996) 1.59
Shedding of the glycoprotein from vesicular stomatitis virus-infected cells. J Virol (1978) 1.59
NH2-terminally truncated HER-2/neu protein: relationship with shedding of the extracellular domain and with prognostic factors in breast cancer. Cancer Res (1998) 1.57
Chemical characterization of A beta 17-42 peptide, a component of diffuse amyloid deposits of Alzheimer disease. J Biol Chem (1994) 1.56
Effect of RNase III on efficiency of translation of bacteriophage T7 lysozyme mRNA. J Virol (1978) 1.56
The formation of poliovirus proteins. Cold Spring Harb Symp Quant Biol (1969) 1.52
Genomic cloning, characterization, and multilineage growth-promoting activity of human granulocyte-macrophage colony-stimulating factor. Proc Natl Acad Sci U S A (1986) 1.46
Phosphoproteins of vesicular stomatitis virus: identity and interconversion of phosphorylated forms. Virology (1979) 1.46
Reversible inhibition of interferon synthesis by puromycin: evidence for an interferon-specific messenger RNA. Proc Natl Acad Sci U S A (1965) 1.44
The parovivirus MVM: particles with altered structural proteins. Virology (1975) 1.44
Conservation of the sequence of the Alzheimer's disease amyloid peptide in dog, polar bear and five other mammals by cross-species polymerase chain reaction analysis. Brain Res Mol Brain Res (1991) 1.44
The parvovirus MVM: a comparison of heavy and light particle infectivity and their density conversion in vitro. Virology (1976) 1.43
cDNA sequence analysis of a 29-kDa cysteine-rich surface antigen of pathogenic Entamoeba histolytica. Proc Natl Acad Sci U S A (1990) 1.43
Phenotypic mixing between human immunodeficiency virus and vesicular stomatitis virus or herpes simplex virus. J Acquir Immune Defic Syndr (1990) 1.42
Functional cloning vectors for use in directional cDNA cloning using cohesive ends produced with T4 DNA polymerase. Gene (1992) 1.40
Distribution of phosphoserine, phosphothreonine and phosphotyrosine in proteins of vesicular stomatitis virus. Virology (1981) 1.34
Synthesis and distribution of vesicular stomatitis virus-specific polypeptides in the absence of progeny production. Virology (1977) 1.31
Murine infection by vesicular stomatitis virus: initial characterization of the H-2d system. J Virol (1991) 1.30
Polymerase activity in lymphocyte culture supernatants from patients with Kawasaki disease. Nature (1986) 1.21
RNA synthesis of vesicular stomatitis virus. VII. Complete separation of the mRNA's of vesicular stomatitis virus by duplex formation. J Virol (1977) 1.20
Global ischemia activates nuclear factor-kappa B in forebrain neurons of rats. Stroke (1997) 1.19
Propeptide of human protein C is necessary for gamma-carboxylation. Biochemistry (1987) 1.18
RNA synthesis of vesicular stomatitis virus. VIII. Oligonucleotides of the structural genes and mRNA. Gene (1979) 1.16
Interferon-mediated inhibition of virion-directed transcription. Virology (1972) 1.15
Synthesis of a small RNA in cells coinfected by standard and defective interfering particles of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1979) 1.15
Preparative polyacrylamide gel electrophoresis of ribonucleic acid. Identification of multiple molecular species of bacteriophage T7 lysozyme messenger ribonucleic acid. Biochemistry (1974) 1.13
Role of carbohydrate in the function of human granulocyte-macrophage colony-stimulating factor. Biochemistry (1987) 1.12
Membrane anchors of vesicular stomatitis virus: characterization and incorporation into virions. J Virol (1988) 1.11
A soluble protein related to the HER-2 proto-oncogene product is released from human breast carcinoma cells. Oncogene (1991) 1.11
SKOV3 ovarian carcinoma cells have functional estrogen receptor but are growth-resistant to estrogen and antiestrogens. J Steroid Biochem Mol Biol (1995) 1.09
Pseudotype formation between enveloped RNA and DNA viruses. Nature (1974) 1.09
Progesterone receptor messenger ribonucleic acid and protein are overexpressed in human uterine leiomyomas. Am J Obstet Gynecol (1993) 1.09
Differentiation dependent expression of tensin and cortactin in chicken osteoclasts. Cell Motil Cytoskeleton (1995) 1.08
Cloning and characterization of an abundant subtype of the human calcitonin receptor. Mol Pharmacol (1994) 1.08
Study of refractive index of GeO2:SiO2 mixtures using deposited-thin-film optical waveguides. Appl Opt (1985) 1.07
Effect of ribavirin on macromolecular synthesis in vesicular stomatitis virus-infected cells. Antimicrob Agents Chemother (1986) 1.06
Ribonucleic acid synthesis of vesicular stomatitis virus. VI. Correlation of defective particle RNA synthesis with standard RNA replication. J Mol Biol (1974) 1.06
Host-dependent phosphorylation and kinase activity associated with vesicular stomatitis virus. J Biol Chem (1982) 1.05
Defective interfering virus particles modulate virulence. J Virol (1985) 1.04
Human prostatic acid phosphatase has phosphotyrosyl protein phosphatase activity. Biochem J (1986) 1.03
Further characterization of the vesicular stomatitis virus temperature-sensitive O45 mutant: intracellular conversion of the glycoprotein to a soluble form. J Virol (1986) 1.01
Human genes for complement components C1r and C1s in a close tail-to-tail arrangement. Proc Natl Acad Sci U S A (1988) 1.01
The HER-2/neu receptor tyrosine kinase gene encodes a secreted autoinhibitor. Proc Natl Acad Sci U S A (1999) 1.00
The use of conserved cellulase family-specific sequences to clone cellulase homologue cDNAs from Fusarium oxysporum. Gene (1994) 1.00
Interference among defective interfering particles of vesicular stomatitis virus. J Virol (1982) 0.99
Cytolytic T lymphocytes from the BALB/c-H-2dm2 mouse recognize the vesicular stomatitis virus glycoprotein and are restricted by class II MHC antigens. J Immunol (1990) 0.99
The spectrum of human kallikrein 6 (zyme/protease M/neurosin) expression in human tissues as assessed by immunohistochemistry. J Histochem Cytochem (2001) 0.96
An effect of temperature on the Bacillus subtillis transfer RNA's which respond to codons beginning with U and A correlation with cytokinin activity. Biochim Biophys Acta (1970) 0.96
Defective interfering particles of vesicular stomatitis virus: structure-function relationships. Ann N Y Acad Sci (1980) 0.96
Estrogen receptor gene expression in human uterine leiomyomata. J Clin Endocrinol Metab (1995) 0.96
Effect of RNase III on the size of bacteriophage T7 lysozyme mRNA. J Virol (1978) 0.96
RNA synthesis of vesicular stomatitis virus. X. Transcription and replication by defective interfering particles. J Virol (1980) 0.95